Interleukin-17A Antagonist [EPC] class drugs

2 results
  • cosentyx - secukinumab injection

    (Secukinumab)
    Novartis Pharmaceuticals Corporation
    Cosentyx treats moderate-to-severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, enthesitis-related arthritis, and moderate-to-severe hidradenitis suppurativa in eligible adults and pediatric patients.
  • taltz - ixekizumab injection, solution

    (Ixekizumab)
    Eli Lilly And Company
    TALTZ treats moderate-to-severe plaque psoriasis in patients 6 and older who are candidates for systemic therapy or phototherapy, and in adults with active psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis with objective signs of inflammation.